InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65
United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
Barry Ticho
2 Nov 2026
Chief Medical Officer
Sold on a plan
200
$26.99
$5.40K
Barry Ticho
2 Nov 2026
Chief Medical Officer
Sold on a plan
6,995
$26.38
$184.51K
Jonathan Allan
2 Oct 2026
General Counsel & Corp Sec
Sold on a plan
627
$26.33
$16.51K
Barry Ticho
1 Oct 2026
Chief Medical Officer
Sold on a plan
1,051
$26.16
$27.49K
Barry Ticho
1 Sep 2026
Chief Medical Officer
Sold on a plan
1,600
$31.06
$49.69K
Barry Ticho
1 Sep 2026
Chief Medical Officer
Sold on a plan
3,945
$30.51
$120.37K
Barry Ticho
3 Aug 2026
Chief Medical Officer
Sold on a plan
1,269
$29.45
$37.38K
Barry Ticho
3 Aug 2026
Chief Medical Officer
Sold on a plan
5,907
$28.95
$171.01K
Barry Ticho
1 Jul 2026
Chief Medical Officer
Sold on a plan
500
$33.27
$16.63K
Barry Ticho
1 Jul 2026
Chief Medical Officer
Sold on a plan
6,728
$32.62
$219.43K
Jonathan Allan
16 Jun 2026
General Counsel & Corp Sec
Sold on a plan
1,457
$29.95
$43.64K
Barry Ticho
1 Jun 2026
Chief Medical Officer
Sold on a plan
1,795
$30.58
$54.89K
Barry Ticho
1 May 2026
Chief Medical Officer
Sold on a plan
2,243
$32.79
$73.55K
Barry Ticho
1 Apr 2026
Chief Medical Officer
Sold on a plan
1,838
$32.66
$60.03K
Jonathan Allan
20 Mar 2026
General Counsel & Corp Sec
Sold on a plan
601
$34.41
$20.68K
Jonathan Allan
20 Mar 2026
General Counsel & Corp Sec
Sold on a plan
8,692
$33.64
$292.36K
Barry Ticho
18 Mar 2026
Chief Medical Officer
Sold on a plan
103
$32.85
$3.38K
Barry Ticho
18 Mar 2026
Chief Medical Officer
Sold on a plan
483
$31.79
$15.35K
Barry Ticho
18 Mar 2026
Chief Medical Officer
Sold on a plan
6,100
$31.28
$190.83K
Barry Ticho
17 Mar 2026
Chief Medical Officer
Sold on a plan
2,587
$33.38
$86.34K
Barry Ticho
17 Mar 2026
Chief Medical Officer
Sold on a plan
3,577
$32.74
$117.11K
Arthur A Levin
13 Mar 2026
Director
Sold on a plan
605
$36.80
$22.26K
Adrian R. Krainer
10 Mar 2026
Director
Sold on a plan
33,243
$39.74
$1.32M
Adrian R. Krainer
2 Mar 2026
Director
Sold on a plan
7,229
$39.66
$286.72K
Edward M. MD Kaye
8 Dec 2025
Director
Sold on a plan
1,331
$33.10
$44.06K
Edward M. MD Kaye
8 Dec 2025
Director
Sold on a plan
8,274
$32.52
$269.07K
Edward M. MD Kaye
8 Dec 2025
Director
Sold on a plan
3,825
$31.44
$120.25K
Jonathan Allan
8 Dec 2025
General Counsel & Corp Sec
Sold on a plan
2,678
$32.61
$87.34K
Jonathan Allan
8 Dec 2025
General Counsel & Corp Sec
Sold on a plan
1,300
$31.60
$41.07K
Jonathan Allan
5 Dec 2025
General Counsel & Corp Sec
Sold on a plan
2,344
$31.76
$74.44K
Jonathan Allan
5 Dec 2025
General Counsel & Corp Sec
Sold on a plan
5,437
$31.08
$169.00K
Jonathan Allan
5 Dec 2025
General Counsel & Corp Sec
Sold on a plan
1,004
$31.33
$31.46K
Edward M. MD Kaye
5 Dec 2025
Director
Sold on a plan
500
$31.85
$15.92K
Edward M. MD Kaye
5 Dec 2025
Director
Sold on a plan
1,681
$31.15
$52.36K
Edward M. MD Kaye
5 Dec 2025
Director
Sold on a plan
6,367
$31.33
$199.48K
Barry Ticho
5 Dec 2025
Chief Medical Officer
Sold on a plan
1,989
$31.35
$62.35K
Barry Ticho
5 Dec 2025
Chief Medical Officer
Sold on a plan
1,673
$31.33
$52.42K
Jonathan Allan
4 Dec 2025
General Counsel & Corp Sec
Sold on a plan
194
$31.32
$6.08K
Jonathan Allan
4 Dec 2025
General Counsel & Corp Sec
Sold on a plan
824
$30.76
$25.35K
Edward M. MD Kaye
4 Dec 2025
Director
Sold on a plan
1,231
$31.32
$38.55K
Edward M. MD Kaye
4 Dec 2025
Director
Sold on a plan
5,222
$30.76
$160.65K
Barry Ticho
4 Dec 2025
Chief Medical Officer
Sold on a plan
323
$31.32
$10.12K
Barry Ticho
4 Dec 2025
Chief Medical Officer
Sold on a plan
1,373
$30.76
$42.24K
Adrian R. Krainer
24 Nov 2025
Director
Sold on a plan
40,472
$29.72
$1.20M
Adrian R. Krainer
14 Nov 2025
Director
Sold on a plan
20,682
$27.34
$565.37K
Adrian R. Krainer
14 Nov 2025
Director
Sold on a plan
19,790
$26.61
$526.69K
Show all 81 transactions →

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 2
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 261,194
History held since 20 Jun 2019